Amgen To Discuss Data Supporting Biologics License Application For ABP 501, A Biosimilar Candidate To Adalimumab

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. PSKY
2. META
3. NVDA
4. LGND
5. SPY
6. MONC:IM
7. PTON
8. NYXH
9. MONRY
10. DGX

Go back to Amgen To Discuss Data Supporting Biologics License Application For ABP 501, A Biosimilar Candidate To Adalimumab
Amgen Inc (NASDAQ: AMGN) Delayed: 393.16 --0 (-0%)
Previous Close $393.16    52 Week High $176.85 
Open $393.16    52 Week Low $133.64 
Day High $393.16    P/E 59.21 
Day Low $393.16    EPS $6.64 
Volume 37,388